Flow-Diverter Stenting of Intracavernous Internal Carotid Artery Mycotic Aneurysm

This is the first reported case in which a mycotic aneurysm refractory to the first medical treatment was treated with a Pipeline embolization device (PED), and the first case of a mycotic aneurysm from Brucella treated by endovascular therapy. A 35-year-old man presented with left eye pain and ptos...

Full description

Saved in:
Bibliographic Details
Published inJournal of Stroke and Cerebrovascular Diseases Vol. 28; no. 7; pp. e81 - e82
Main Authors Imamura, Hirotoshi, Sakai, Nobuyuki, Alexander, Michael J.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.07.2019
Elsevier BV
Subjects
Online AccessGet full text
ISSN1052-3057
1532-8511
1532-8511
DOI10.1016/j.jstrokecerebrovasdis.2019.04.026

Cover

More Information
Summary:This is the first reported case in which a mycotic aneurysm refractory to the first medical treatment was treated with a Pipeline embolization device (PED), and the first case of a mycotic aneurysm from Brucella treated by endovascular therapy. A 35-year-old man presented with left eye pain and ptosis, and fever for 2 weeks. Before symptom onset, he visited Vietnam where he developed a flu-like illness; however, antibiotics were ineffective. We suspected Brucella as the most likely infectious etiology for the patient's intracavernous aneurysm. Since the aneurysm did not reduce in size following 2 weeks of antibiotic therapy, we placed a PED in the left internal carotid artery. Follow-up angiogram 4 months later showed no residual aneurysm, and cranial nerve palsies had completely resolved. From the results of this case, it appears that flow diverter stenting may be a safe and effective treatment of mycotic aneurysms of the cavernous segment of ICA.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1052-3057
1532-8511
1532-8511
DOI:10.1016/j.jstrokecerebrovasdis.2019.04.026